Kaustubh Kale

Principal investigator.

Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$13.1MFederal grants as PI22 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20152026
AwardsPatents
Federal awards as principal investigator

22 awards · $13.1M

DateAgencyAwardAmountCompany
Sep 17, 2026NIHSBIR Phase I
A Smart Remote Monitoring System for Cardiometabolic Management in Patients with Alzheimer's and Related Dementia
$500K—
Jul 22, 2026NIHSBIR Phase II
Non-invasive cloud connected device for hemodynamic-guided therapy to improve outcomes for heart failure patients
$1.2M—
Sep 5, 2025NIHSTTR Phase I
An Innovative AI-Powered Wearable Physiological Sensor System for Real-Time Pain Monitoring and Management (PainVitals)
$350K—
Aug 2, 2025NIHSBIR Phase II
A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring.
$860K—
Jul 15, 2024NIHSBIR Phase II
A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring.
$865K—
Apr 1, 2023NIHSBIR Phase II
A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring.
$400K—
Dec 2, 2022NIHSBIR Phase II
Administrative Supplement to Promote Diversity in Research and Development Small Businesses-SBIR (EF)
$75K—
Apr 14, 2022NIHSBIR Phase II
A novel non-invasive device for screening and optimized management to improve heart failure outcomes in patients with diabetes mellitus
$1.5M—
Sep 18, 2021NIHSBIR Phase I
Innovative, non-invasive, battery-less, disposable cardiac biosensor for hemodynamic monitoring
$225K—
Jul 8, 2021NIHSBIR Phase II
Administrative Supplement to Promote Diversity in Research and Development Small Businesses-SBIR (Rodrigo Jordao)
$134K—
Jul 7, 2021NIHSBIR Phase II
Non-invasive cloud connected device for hemodynamic-guided therapy toimprove outcomes for heart failure patients
$1.5M—
Apr 23, 2021NIHSBIR Phase II
A novel non-invasive device for screening and optimized management to improve heart failure outcomes in patients with diabetes mellitus
$1.5M—
Sep 19, 2020NIHSBIR Phase II
Screening Under REgular assessment with hemoTAG (SURE TAG)
$190K—
Apr 7, 2020NIHSBIR Phase II
A novel non-invasive device for screening and optimized management to improve heart failure outcomes in patients with diabetes mellitus
$400K—
Mar 1, 2020NIHSBIR Phase II
Non-invasive cloud connected device for hemodynamic-guided therapy toimprove outcomes for heart failure patients
$1.5M—
May 23, 2019NIHSBIR Phase II
Non-invasive cloud connected device for hemodynamic-guided therapy toimprove outcomes for heart failure patients
$225K—
Jan 2, 2019NIHSBIR Phase II
A mobile framework to measure ejection fraction by automated non-invasive analysis of cardiac signals
$400K—
Jan 31, 2018NIHSBIR Phase II
A mobile framework to measure ejection fraction by automated non-invasive analysis of cardiac signals
$400K—
Jun 13, 2017NIHSBIR Phase II
A mobile framework to measure ejection fraction by automated non-invasive analysis of cardiac signals
$400K—
Jun 5, 2017NIHSBIR Phase I
Innovation for the earlydetection, diagnosis, and quantification of diabetic cardiomyopathy.
$225K—
Sep 29, 2015NIHSBIR Phase I
A mobile framework to measure ejection fraction by automated non-invasive analysi
$63K—
Jul 6, 2015NIHSBIR Phase I
A mobile framework to measure ejection fraction by automated non-invasive analysi
$200K—
Among 1,601 researchers in this sector

Peer ranks

Federal funding#10
Awards as PI#9
Patents#27
From filings, awards and patents

Companies

No tracked company linked yet.

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.